120
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Quercetin inhibits transforming growth factor β1-induced epithelial–mesenchymal transition in human retinal pigment epithelial cells via the Smad pathway

, , , , , , , , , , & show all
Pages 4149-4161 | Published online: 06 Dec 2018

References

  • SadakaAGiuliariGPProliferative vitreoretinopathy: current and emerging treatmentsClin Ophthalmol201261325133322942638
  • PastorJCRojasJPastor-IdoateSDi LauroSGonzalez-BuendiaLDelgado-TiradoSProliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequencesProg Retin Eye Res20165112515526209346
  • ShuDYLovicuFJMyofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosisProg Retin Eye Res201760446528807717
  • MorescalchiFDuseSGambicortiERomanoMRCostagliolaCSemeraroFProliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidMediators Inflamm2013201326978724198445
  • CaiWWeiQLiuQEffect of bradykinin on TGF-β1-induced retinal pigment epithelial cell proliferation and extracellular matrix secretionBMC Ophthalmol201616119927832751
  • WeiQLiuQRenCEffects of bradykinin on TGF-β1-induced epithelial-mesenchymal transition in ARPE-19 cellsMol Med Rep20181745878588629436636
  • RenYXMaJXZhaoFAnJBGengYXLiuLYEffects of curcumin on epidermal growth factor in proliferative vitreoretinopathyCell Physiol Biochem20184752136214629975931
  • QiuSJiangZHuangZMigration of retinal pigment epithelium cells is regulated by protein kinase Cα in vitroInvest Ophthalmol Vis Sci201354107082709024084091
  • González-AvilaGMéndezDLozanoDRamosCDelgadoJIturriaCRole of retinal detachment subretinal fluid on extracellular matrix metabolismOphthalmologica20042181495614688436
  • LinHYChenYSWangKChienHWHsiehYHYangSFFisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expressionMol Vis20172390091029296070
  • SrinivasanPVijayakumarSKothandaramanSPalaniMAnti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approachesJ Pharm Anal20188210911829736297
  • CaiHDSuSLQianDWRenal protective effect and action mechanism of Huangkui capsule and its main five flavonoidsJ Ethnopharmacol201720615215928408246
  • WangJQianXGaoQQuercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitroJ Ovarian Res20181115129929541
  • MengLQYangFYWangMSQuercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathwaysProstate2018781179080029654614
  • Şeker KaratoprakGAydinGAltinsoyBAltinkaynakCKoşarMOcsoyIThe effect of pelargonium endlicherianum Fenzl. root extracts on formation of nanoparticles and their antimicrobial activitiesEnzyme Microb Technol201797212628010769
  • BalakrishnanSBhatFARaja SinghPGold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancerCell Prolif201649667869727641938
  • SongWZhaoXXuJZhangHQuercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptorOncol Lett20171433343334828927086
  • YuDYeTXiangYQuercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cellsOnco Targets Ther2017104719472929026320
  • PatelDHSharmaNInhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gelsOnco Targets Ther201696445645927799792
  • KookDWolfAHYuALThe protective effect of quercetin against oxidative stress in the human RPE in vitroInvest Ophthalmol Vis Sci20084941712172018385095
  • DuLHaoMLiCQuercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathwayMol Cell Endocrinol2017452445628501572
  • OhHNKimCELeeJHYangJWEffects of Quercetin in a Mouse Model of Experimental Dry EyeCornea20153491130113626203745
  • XuXRYuHTYangYHangLYangXWDingSHQuercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathwayEur J Pharmacol20167701826643168
  • StoddardARKoetjeLRMitchellAKSchotanusMPUbelsJLBioavailability of antioxidants applied to stratified human corneal epithelial cellsJ Ocul Pharmacol Ther201329768168723634787
  • YuJLiuFCuiSJVitreous proteomic analysis of proliferative vitreoretinopathyProteomics20088173667367818752205
  • SuCCChanCMChenHMLutein inhibits the migration of retinal pigment epithelial cells via cytosolic and mitochondrial Akt pathways (lutein inhibits RPE cells migration)Int J Mol Sci2014158137551376725110866
  • KhanMABradyCJKaiserRSClinical management of proliferative vitreoretinopathy: an updateRetina201535216517525602631
  • EastlakeKBanerjeePJAngbohangACharterisDGKhawPTLimbGAMüller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathyGlia201664449550626556395
  • MorescalchiFDuseSGambicortiERomanoMRCostagliolaCSemeraroFProliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidMediators Inflamm2013201326978724198445
  • GarwegJGTappeinerCHalberstadtMPathophysiology of proliferative vitreoretinopathy in retinal detachmentSurv Ophthalmol201358432132923642514
  • CiprianDThe pathogeny of proliferative vitreoretinopathyRom J Ophthalmol2015592889226978867
  • HoersterRFauserSCursiefenCKirchhofBHeindlLMThe influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathyGraefes Arch Clin Exp Ophthalmol201725591721172528600710
  • SunalpMWiedemannPSorgenteNRyanSJEffects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection modelCurr Eye Res1984346196236425019
  • JonasJBKreissigIDegenringRFTreatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonideKlin Monbl Augenheilkd20032206384390 German12830391
  • MoysidisSNThanosAVavvasDGMechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedsideMediators Inflamm2012201281593723049173
  • IshikawaKHeSTerasakiHResveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathySci Rep201551638626552368
  • AlexAFSpitznasMTittelAPKurtsCEterNInhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitroCurr Eye Res201035111021103320958191
  • ZhouXKuangXLongCCurcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells Via Multiple PathwaysCurr Mol Med201717431231929110611
  • KviecinskiMRFelipeKBCorreiaJFBrazilian Bidens pilosa Linné yields fraction containing quercetin-derived flavonoid with free radical scavenger activity and hepatoprotective effectsLibyan J Med201165651
  • FengJSongDJiangSQuercetin restrains TGF-β1-induced epithelial-mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expressionBiochem Biophys Res Commun2018498113213829425820
  • FerlemiAVMakriOEMermigkiPGLamariFNGeorgakopoulosCDQuercetin glycosides and chlorogenic acid in highbush blueberry leaf decoction prevent cataractogenesis in vivo and in vitro: Investigation of the effect on calpains, antioxidant and metal chelating propertiesExp Eye Res201614525826826808488
  • WangZLuYShengBDingYChengXCatalpol inhibits TGF-β1-induced epithelial-mesenchymal transition in human non-small-cell lung cancer cells through the inactivation of Smad2/3 and NF-κB signaling pathwaysJ Cell Biochem Epub2018117
  • ChenCLChenYHTaiMCLiangCMLuDWChenJTResveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathwayDrug Des Devel Ther201711163173
  • JiXWangHWuZSpecific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 SignalingMed Sci Monit2018241633164129555895
  • ZhangZHLiMHLiuDRhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney DiseaseFront Pharmacol20189102930271345
  • MaLZengYWeiJKnockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylationBiomed Pharmacother20181071728173530257391
  • ZengYZhuJShenDRepression of Smad4 by miR-205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell linesInt J Oncol201649270070827279345
  • TaoSLiuMShenDZhangWWangTBaiYTGF-β/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant GliomaDNA Cell Biol Epub2018919
  • WuLZhangQMoWQuercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathwaysSci Rep201771928928839277
  • XinXLiXHWuJZPentamethylquercetin ameliorates fibrosis in diabetic Goto-Kakizaki rat kidneys and mesangial cells with suppression of TGF-β/Smads signalingEur J Pharmacol20137131–361523665496
  • LuHWuLLiuLQuercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarizationBiochem Pharmacol201815420321229753749